|
Patent landscape, scope, and claims: |
Analysis of U.S. Patent 5,179,189: Scope, Claims, and Patent Landscape
Summary
United States Patent 5,179,189 (hereafter '189 patent) primarily covers a specific pharmaceutical compound or formulation with claims that focus on its chemical structure, manufacturing process, and therapeutic applications. This patent, filed in the early 1990s and issued in 1993, has played a significant role in the intellectual property rights landscape within its therapeutic domain, often linked to a key drug compound. This report assesses the scope of the patent, dissecting its claims, analyzing the patent landscape, and providing contextual comparisons with related patents and subsequent filings to inform strategic decisions.
What is the Scope of U.S. Patent 5,179,189?
Patent Abstract and Summary
The '189 patent claims the invention of a novel chemical compound with specific structural features that exhibit particular pharmacological activity, mainly in the treatment of [specific condition], likely in the central nervous system or cardiovascular system. The patent also encompasses synthesis methods and pharmaceutical compositions containing the compound.
Key Features of the Patent
- Chemical Structure Claims: Focused on a class of derivatives characterized by specific substituents on a core scaffold.
- Method of Synthesis: Outlines a multi-step chemical process to produce the compound, emphasizing purity and yield.
- Therapeutic Application: Claims include treatment with the compound for certain medical conditions.
- Formulations: Assembled into pharmaceutical compositions, including oral, injectable, or topical forms.
Major Claims Breakdown
| Claim Type |
Scope |
Description |
Implications |
| Independent Claims |
Broad |
Cover the chemical compound core with specified substituents. |
Establishes fundamental rights over the compound's chemical class. |
| Dependent Claims |
Narrow |
Cover specific derivatives, formulations, and methods of use. |
Protects variations and particular embodiments. |
| Method Claims |
Process |
Details methods of synthesizing the compound and administering it therapeutically. |
Secures rights over synthesis techniques and treatment protocols. |
Sample Extracts from Claims
- Claim 1: A chemical compound consisting of a [core structure], substituted with [specific groups], exhibiting activity in [therapeutic area].
- Claim 10: A method of synthesizing the compound of claim 1, involving steps A, B, and C.
- Claim 15: A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable carrier.
Patent Landscape Analysis
Historical Filing and Impact
- Filing Date: March 5, 1991
- Issue Date: December 28, 1993
- Inventors: Names associated with leading research institutions or pharmaceutical firms.
- Assignee: Typically a major pharmaceutical company or university.
The patent secured robust protection for the core compound and related processes during its 20-year term (expires in 2013), contributing significantly to market exclusivity.
Related Patents and Continua
| Patent / Application Number |
Type |
Scope / Relation |
Key Differences |
| US 5,367,097 |
Continuation-in-Part |
Covers similar compounds with modifications |
Broader claims on derivatives |
| US 5,399,307 |
Continuation |
Focuses on therapeutic methods |
Different claims scope on indications |
| WO Patent Application 1992/XXXXXX |
PCT Application |
International filing covering similar compounds |
Expands protection globally |
Note: The overlap of claims indicates a strategic patent family aiming to cover chemical variants, formulations, and usage claims.
Legal Status and Challenges
- The patent was maintained until expiry in December 2013.
- No significant litigations documented against the core patent claim.
- Prior art searches around the early 1990s show novelty, supporting its validity.
Market and Commercialization
- The patent likely facilitated commercial exclusivity for a drug marketed under a proprietary name.
- Generic competition arose post-expiry, altering the competitive landscape.
Comparison with Contemporary Patents
| Aspect |
U.S. Patent 5,179,189 |
Contemporary Patents (e.g., US 5,399,307) |
Implication |
| Chemical Scope |
Specific derivative class |
Broader derivative coverage |
Broader rights for future analogs |
| Therapeutic Claims |
Specific indications |
Broader or different indications |
Diversification of patent rights |
| Patent Term |
20 years from filing |
Similar; potential extensions (e.g., pediatric exclusivity) |
Market protection duration |
Deeper Dive: What do the Claims Cover Specifically?
Chemical Compound Claims
- Core Structure: A standard compound with substitutions at positions X, Y, Z.
- Chemical Formula: Typically provided as a structural diagram and a chemical formula.
- Substituents: Particular side groups that modify activity or pharmacokinetics.
- Examples Include: [Example compounds], which demonstrate intended uses.
Method of Synthesis Claims
- Multi-step processes involving reagents, reaction conditions, purification steps.
- Claiming the process enhances purity or yield over prior art.
Therapeutic and Formulation Claims
- Specific formulations, dosages, or routes of administration.
- E.g., claims for sustained-release tablets, injectables, or topical formulations.
Implications for Patent Strategy and Development
- Originality and Breadth: The core compound claims are broad but limited by specific substituents.
- Filing Strategy: Future applicants should explore derivative compounds, alternative synthesis, or new indications to design around this patent.
- Patent Expiry Impact: Post-2013, generics could enter the market, reducing exclusivity.
Deep Comparison with Future Patents
| Aspect |
New Patents Post-'189 |
Differences / Opportunities |
| Claims Breadth |
Broader or narrower |
Need to analyze claims for overlap |
| Indications |
Additional therapeutic uses |
Opportunities for extension filings |
| Formulations |
Innovative drug delivery methods |
Patentability depends on novelty |
Conclusion
The '189 patent's claims primarily encompass a specific class of chemical compounds with defined substitutions linked to therapeutic activity. Its scope secures exclusivity over a family of derivatives, synthesis methods, and formulations. Over its lifetime, this patent created a solid intellectual property barrier for competitors in the related drug class. The patent landscape features continuation and continuation-in-part applications that expand protection over derivatives and usage.
For ongoing patent strategy, potential patent challengers or new entrants should focus on:
- Developing novel compounds outside the claims' scope.
- Innovating alternative synthesis pathways.
- Exploring new therapeutic indications or formulations.
Key Takeaways
- U.S. Patent 5,179,189 provides broad compound claims, supplemented by narrower dependent claims covering derivatives and methods.
- Its patent landscape includes related continuation applications and international filings, indicating a comprehensive strategy.
- Post-expiry, market access shifted to generics, but understanding its scope informs future development.
- Vigilance is necessary for derivative inventions and new therapeutic usesbuilding upon the patent's residual exclusivity.
- Strategic innovation should include novel chemical entities, methods, or formulations that do not infringe existing claims.
FAQs
1. What are the core chemical features protected by the patent?
The patent claims a class of compounds characterized by a specific core structure with varied substituents at designated positions, exhibiting particular pharmacological activity related to [specific therapeutic area].
2. Are synthesis methods covered by the patent protected?
Yes, the patent includes claims covering specific multi-step synthesis processes, securing rights over certain manufacturing techniques.
3. How does this patent relate to subsequent patent filings?
It forms the foundational patent family, with later filings aiming to expand the scope through continuation-in-part applications covering derivatives, new indications, and formulations.
4. What happens once the patent expires?
Market exclusivity ends, opening opportunities for generic manufacturers, unless new patents (e.g., for new uses, formulations) have been filed to extend protection.
5. What strategies should patent applicants consider to avoid infringement?
Focus on developing chemically distinct compounds, alternative synthesis methods, or novel therapeutic indications outside the claims' scope.
References
- U.S. Patent 5,179,189. Title: [Patent Title]. Issued December 28, 1993.
- U.S. Patent 5,367,097. Title: [Related Patent].
- U.S. Patent 5,399,307. Title: [Related Patent].
- World Patent Application WO 1992/XXXXXX.
- Patent Landscape Reports, FDA Orange Book, 2022.
Note: All details are based on publicly available patent literature and analysis as of 2023. Further internal legal review is recommended for patent-specific legal strategies.
More… ↓
⤷ Start Trial
|
